These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 23046673)

  • 1. Transarterial therapies for hepatocellular carcinoma (HCC): a long way towards standardization.
    Tsochatzis EA; Meyer T; O'Beirne J; Burroughs AK
    J Hepatol; 2013 Jan; 58(1):194. PubMed ID: 23046673
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to: "Transarterial therapies for hepatocellular carcinoma (HCC): a long way towards standardization".
    Park JW; Kim HB; Lee IJ
    J Hepatol; 2013 Jan; 58(1):195. PubMed ID: 23046675
    [No Abstract]   [Full Text] [Related]  

  • 3. Safety of transarterial chemoembolization plus sorafenib combination treatment in unresectable hepatocellular carcinoma.
    Sinakos E; Dedes I; Papalavrentios L; Drevelegas A; Akriviadis E
    Scand J Gastroenterol; 2010 Apr; 45(4):511-2. PubMed ID: 20113152
    [No Abstract]   [Full Text] [Related]  

  • 4. TACE with or without systemic therapy?
    Dufour JF
    J Hepatol; 2012 Jun; 56(6):1224-5. PubMed ID: 22402292
    [No Abstract]   [Full Text] [Related]  

  • 5. [The treatment of hepatocellular carcinoma. New developments].
    Kuiken SD; van Delden OM; Richel DJ; Jansen PL
    Ned Tijdschr Geneeskd; 2009 Apr; 153(14):668-72. PubMed ID: 19425326
    [No Abstract]   [Full Text] [Related]  

  • 6. Management of hepatocellular carcinoma with transarterial chemoembolization in the era of systemic targeted therapy.
    Lencioni R
    Crit Rev Oncol Hematol; 2012 Aug; 83(2):216-24. PubMed ID: 22142656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Closing remarks.
    Kudo M
    Clin Drug Investig; 2012 Aug; 32 Suppl 2():52. PubMed ID: 22873627
    [No Abstract]   [Full Text] [Related]  

  • 8. Major achievements in hepatocellular carcinoma.
    Bruix J; Llovet JM
    Lancet; 2009 Feb; 373(9664):614-6. PubMed ID: 19231618
    [No Abstract]   [Full Text] [Related]  

  • 9. Phase II study of concurrent transarterial chemoembolization and sorafenib in patients with unresectable hepatocellular carcinoma.
    Park JW; Koh YH; Kim HB; Kim HY; An S; Choi JI; Woo SM; Nam BH
    J Hepatol; 2012 Jun; 56(6):1336-42. PubMed ID: 22314421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Markedly effective local control of hepatocellular carcinoma with a poor prognosis by combined multimodal therapy with sorafenib as a neoadjuvant approach.
    Bathaix F; Marion D; Cuinet M; Maillard E; Zoulim F; Mornex F; Merle P
    Gastroenterol Clin Biol; 2010; 34(4-5):314-8. PubMed ID: 20207091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocellular carcinoma: the role of the North American GI Steering Committee Hepatobiliary Task Force and the advent of effective drug therapy.
    O'Neil BH; Venook AP
    Oncologist; 2007 Dec; 12(12):1425-32. PubMed ID: 18165619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment algorithm for intermediate and advanced stage hepatocellular carcinoma: Korea.
    Choi JY
    Oncology; 2011; 81 Suppl 1():141-7. PubMed ID: 22212948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hepatocellular carcinoma: what's new?].
    Teufel A; Marquardt JU; Galle PR; Wörns M
    Dtsch Med Wochenschr; 2012 Feb; 137(5):210-3. PubMed ID: 22250042
    [No Abstract]   [Full Text] [Related]  

  • 14. Sorafenib, doesn't it have any competitor in advanced hepatocellular carcinoma?
    Kim DY; Han KH
    J Gastroenterol Hepatol; 2011 Nov; 26(11):1585-6. PubMed ID: 22011294
    [No Abstract]   [Full Text] [Related]  

  • 15. Assessment of the treatment response of HCC.
    Kim KW; Lee JM; Choi BI
    Abdom Imaging; 2011 Jun; 36(3):300-14. PubMed ID: 21279353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential impact of sorafenib on the survival benefit of liver transplantation for hepatocellular carcinoma.
    Vitale A; Lombardi G; Ramirez Morales R; Cillo U
    Dig Liver Dis; 2012 May; 44(5):361-2. PubMed ID: 22424640
    [No Abstract]   [Full Text] [Related]  

  • 17. Intra-arterial infusion of chemotherapy for advanced hepatocellular carcinoma: an Asian perspective.
    Chan SL; Johnson P
    Asia Pac J Clin Oncol; 2012 Jun; 8(2):111-4. PubMed ID: 22524569
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical observation of transarterial chemoembolization combined with sorafenib for advanced hepatocellular carcinoma].
    Xu LT; Chen Z; Lin JH; Zhou ZH; Chen H; Meng ZQ; Liu LM
    Zhonghua Zhong Liu Za Zhi; 2010 Sep; 32(9):703-5. PubMed ID: 21122388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiotherapeutic strategies in the management of hepatocellular carcinoma.
    Lee IJ; Seong J
    Oncology; 2011; 81 Suppl 1():123-33. PubMed ID: 22212946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical analysis of the treatment:transcatheter arterial chemoembolization combined with sorafenib in advanced hepatocellular carcinoma].
    Li Y; Huang JW; Lu LG; Shao PJ; Hu BS; Huang GM; Wei ZG; Zhang L
    Zhonghua Yi Xue Za Zhi; 2010 Aug; 90(31):2187-92. PubMed ID: 21029658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.